4-diphenylacetoxy-1,1-dimethylpiperidinium has been researched along with Pulmonary Hypertension in 1 studies
4-diphenylacetoxy-1,1-dimethylpiperidinium: muscarinic receptor antagonist; RN given refers to parent cpd; do not confuse abbreviation 4-DAMP with a similar cpd which does not contain dimethyl groups
4-DAMP(1+) : A quaternary ammonium salt obtained by formal methylation of the tertiary amino function of 4-diphenylacetoxy-N-methylpiperidine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orii, R | 1 |
| Sugawara, Y | 1 |
| Sawamura, S | 1 |
| Yamada, Y | 1 |
1 other study available for 4-diphenylacetoxy-1,1-dimethylpiperidinium and Pulmonary Hypertension
| Article | Year |
|---|---|
M₃muscarinic receptors mediate acetylcholine-induced pulmonary vasodilation in pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Diamines | 2010 |